Chwiecko J[au] - Search Results

Year	Number of Results
1992	1
1997	1
2001	3
2002	2
2003	5
2004	3
2005	4
2006	3
2007	1
2008	1
2009	4
2011	1
2014	2
2015	1
2023	0

1

[The role of alpha-1-antitrypsin phenotypes in the pathogenesis or rheumatic diseases].

Chwiećko J, Sierakowski S. Chwiećko J, et al. Pol Arch Med Wewn. 2001 May;105(5):409-15. Pol Arch Med Wewn. 2001. PMID: 11865594 Review. Polish. No abstract available.

2

Serum chemokines in patients with rheumatoid arthritis treated with etanercept.

Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. Rheumatol Int. 2011 Apr;31(4):457-61. doi: 10.1007/s00296-009-1299-3. Epub 2009 Dec 19. Rheumatol Int. 2011. PMID: 20024555

3

Serum cytokines in different histological variants of rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. J Rheumatol. 2001 Jun;28(6):1211-7. J Rheumatol. 2001. PMID: 11409111

4

The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.

Klimiuk PA, Kita J, Chwiecko J, Sierakowski S. Klimiuk PA, et al. Among authors: chwiecko j. Clin Rheumatol. 2009 Jan;28(1):17-21. doi: 10.1007/s10067-008-0974-1. Epub 2008 Jul 29. Clin Rheumatol. 2009. PMID: 18663553 Clinical Trial.

5

Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Domyslawska I, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. Clin Exp Rheumatol. 2006 Sep-Oct;24(5):529-33. Clin Exp Rheumatol. 2006. PMID: 17181921

6

Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.

Klimiuk PA, Fiedorczyk M, Sierakowski S, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. Scand J Rheumatol. 2007 Sep-Oct;36(5):345-50. doi: 10.1080/03009740701406460. Scand J Rheumatol. 2007. PMID: 17963163

7

Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.

Klimiuk PA, Sierakowski S, Latosiewicz R, Skowronski J, Cylwik JP, Cylwik B, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. J Rheumatol. 2005 Sep;32(9):1666-72. J Rheumatol. 2005. PMID: 16142858

8

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.

Fiedorczyk M, Klimiuk PA, Sierakowski S, Gindzienska-Sieskiewicz E, Chwiecko J. Fiedorczyk M, et al. Among authors: chwiecko j. J Rheumatol. 2006 Aug;33(8):1523-9. J Rheumatol. 2006. PMID: 16881109

9

Regulation of serum matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 following rituximab therapy in patients with rheumatoid arthritis refractory to anti-tumor necrosis factor blockers.

Klimiuk PA, Domysławska I, Sierakowski S, Chwiećko J. Klimiuk PA, et al. Among authors: chwiecko j. Rheumatol Int. 2015 Apr;35(4):749-55. doi: 10.1007/s00296-014-3112-1. Epub 2014 Sep 5. Rheumatol Int. 2015. PMID: 25190551 Free PMC article.

10

Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis.

Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Klimiuk PA, et al. Among authors: chwiecko j. Rheumatology (Oxford). 2002 Jan;41(1):78-87. doi: 10.1093/rheumatology/41.1.78. Rheumatology (Oxford). 2002. PMID: 11792884

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results